trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Trans-sphenoidal pituitary exploration can be performed with low operative morbidity and mortality.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
5 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that Trans-sphenoidal pituitary exploration can be performed with low operative morbidity and mortality?

Yes. Multiple studies and clinical reviews confirm that trans-sphenoidal pituitary exploration—particularly utilizing modern endoscopic techniques—is a safe and effective first-line intervention associated with low rates of operative morbidity and mortality.

Verdict: SUPPORTED · 5 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently report that trans-sphenoidal approaches (especially endoscopic variants) for pituitary lesions yield high rates of successful resection and endocrine remission while maintaining low rates of severe complications and mortality. No provided papers refute the assertion of low morbidity and mortality for the procedure.

Evidence for · 5
2025
Minimally invasive neurosurgical techniques, such as endoscopic skull base surgery, offer reduced surgical trauma and lower complication rates compared to traditional procedures.
Get citation
S, L., A, P., JE, A. V., A, M., M, G., S, A., S, S., & T, S. (2025). A Comprehensive Review of the Role of the Latest Minimally Invasive Neurosurgery Techniques and Outcomes for Brain and Spinal Surgeries.. doi.org. https://doi.org/10.7759/cureus.84682

See more details
More for · 4
2026
Endoscopic transsphenoidal surgery achieved gross-total resection in 76.7% of giant pituitary adenoma cases with low rates of permanent complications and no major vascular or neurological events.
Get citation
D, O., E, V., A, K., AN, D., P, K., & N, T. (2026). Predicting resection success in giant pituitary adenomas: morphologic determinants and a preoperative multivariate model.. doi.org. https://doi.org/10.3389/fendo.2026.1759071

2026
Comparative outcomes demonstrate that the transsphenoidal approach is associated with significantly lower perioperative mortality and major complications than the transcranial approach.
Get citation
AJR, D., J, R., & MA, A. (2026). Endoscopic Transsphenoidal Versus Transcranial Surgery for Sellar and Suprasellar Tumors: Seven-Year Comparative Outcomes in the Philippines.. doi.org. https://doi.org/10.7759/cureus.110001

2026
Comprehensive institutional data shows that endoscopic transsphenoidal surgery for pituitary adenomas carries low overall rates of severe morbidity and mortality.
Get citation
J, P., DJ, C., KM, K., D, G., I, S., S, D., KG, L., J, S., M, S., RG, B., J, C., & G, Z. (2026). Incidence and predictors of complications, readmission, and reoperation following endoscopic transsphenoidal surgery for pituitary adenomas.. doi.org. https://doi.org/10.3171/2026.2.jns252393

2026
Endoscopic transsphenoidal surgery provides high rates of endocrine remission with minimal surgical morbidity in patients with Cushing's disease.
Get citation
V, G. & P, G. (2026). Outcomes of endoscopic transsphenoidal pituitary surgery in patients with Cushing's disease: A retrospective review.. doi.org. https://doi.org/10.25259/sni_172_2026

What does the evidence say?

The retrieved papers consistently report that trans-sphenoidal approaches (especially endoscopic variants) for pituitary lesions yield high rates of successful resection and endocrine remission while maintaining low rates of severe complications and mortality. No provided papers refute the assertion of low morbidity and mortality for the procedure.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work